Our mission is to develop innovative medicines for the benefit of human health that target serine hydrolases, one of the largest enzyme classes in nature with validated, but mostly untapped therapeutic potential. Hundreds of serine hydrolases exist in humans and include lipases, amidases, esterases, thioesterases, proteases and peptidases, which all share a base-activated serine nucleophile that cleaves an amide or ester bond. Serine hydrolases play a key role in regulating CNS signaling, digestion, metabolism, inflammation, blood clotting, life cycle of viruses and pathogens. The Abide technology selectively and near-universally targets this enzyme class in their native configuration for functional profiling and inhibitor discovery and optimization.
View Top Employees from Abide Therapeutics| Website | https://www.abidetx.com |
| Revenue | $7 million |
| Funding | $2.2 million |
| Employees | 31 (2 on RocketReach) |
| Founded | 2011 |
| Address | 230 Nassau St, Princeton, New Jersey 08540, US |
| Phone | (858) 427-2590 |
| Industry | Pharmaceuticals, Biotechnology, Drug Manufacturing & Research, Consumer Services, Healthcare |
| Competitors | Acetylon Pharmaceuticals, Inc., Corvus Pharmaceuticals, Crinetics Pharmaceuticals, Vividion Therapeutics, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Abide Therapeutics employee's phone or email?
Abide Therapeutics Questions
The Abide Therapeutics annual revenue was $7 million in 2023.
Nikki Scheidecker is the Lmt, Owner of Abide Therapeutics.
2 people are employed at Abide Therapeutics.
Abide Therapeutics is based in Princeton, New Jersey.
The NAICS codes for Abide Therapeutics are [32, 325, 32541, 3254].
The SIC codes for Abide Therapeutics are [283, 2834, 28].
Top Abide Therapeutics Employees
Related Companies
